SCHEMBL514810

SCHEMBL514810

CC(C)CCCCCCCC(CC(=O)[O-])(C(=O)[O-])S(=O)(=O)O.[Na+].[Na+]

nearest known ligand 0.37

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CA1 known ✓ P00915 3/20 0.37
CA2 known ✓ P00918 1/20 0.32
CA4 known ✓ P22748 1/20 0.31
FUT7 Q11130 1/20 0.31
GPR84 Q9NQS5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6363518 1.00 CA1 (0.37) CA1CA2FUT7CA4GPR84
SCHEMBL9777490 0.95 CA1 (0.40) CA1CA2CA4
SCHEMBL1666274 0.83 CES2 (0.39) CA1CA2GPR84
SCHEMBL219970 0.83 CES2 (0.39) CA1CA2GPR84
SCHEMBL2957022 0.83 CES2 (0.39) CA1CA2GPR84
SCHEMBL7967481 0.83 CES2 (0.39) CA1CA2GPR84
SCHEMBL2729135 0.83 CES2 (0.39) CA1CA2GPR84
SCHEMBL10993074 0.83 CES2 (0.39) CA1CA2GPR84
SCHEMBL339202 0.83 CES2 (0.39) CA1CA2GPR84
SCHEMBL11432185 0.83 CES2 (0.39) CA1CA2GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011065855-A1 \"BIOCOMPOSTABLE POLYMER BLENDS\ CABOPOL - INDÚSTRIA DE COMPOSTOS, S.A. (PT) 2011-06-03 WO claimed
US-7138079-B2 Methods for making foamed elastomer gels EDIZONE, LC (US) 2006-11-21 US claimed
US-20030236313-A1 Methods for making foamed elastomer gels EDIZONE, LC 2003-12-25 US claimed
US-5342551-A Containing monoethanolamine citrate, coupler, solvent, alkali CELLO CORPORATION (US) 1994-08-30 US claimed
US-4985162-A SULFOSUCCINATE, NONIONIC SURFACTANT, ANTIFOAM AGENT WEN-DON CORPORATION (US) 1991-01-15 US claimed
US-20260070309-A1 POLYHYDROXYALKANOATE-BASED PACKAGING FILMS AND ARTICLES MADE THEREWITH NEWLIGHT TECHNOLOGIES, INC. (US) 2026-03-12 US disclosed
WO-2025264247-A1 THERMOPLASTIC BLENDS FOR INJECTION MOLDING PLANTSWITCH, INC (US) 2025-12-26 WO disclosed
WO-2025264246-A1 THERMOPLASTIC BLENDS FOR INJECTION MOLDING PLANTSWITCH, INC (US) 2025-12-26 WO disclosed
US-20250215238-A1 AQUEOUS COATING COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC 2025-07-03 US disclosed
US-20250092251-A1 MULTIPHASED POLYHYDROXYALKANOATE-BASED COMPOSITIONS AND ARTICLES MADE THEREFROM NEWLIGHT TECHNOLOGIES, INC. 2025-03-20 US disclosed
EP-4511429-A1 AQUEOUS COATING COMPOSITIONS Dow Global Technologies LLC (US) 2025-02-26 EP disclosed
EP-4479475-A2 MULTIPHASED POLYHYDROXYALKANOATE-BASED COMPOSITIONS AND ARTICLES MADE THEREFROM Newlight Technologies, Inc. (US) 2024-12-25 EP disclosed
US-5364904-A (meth)acrylate copolymer and polyvinyl alcohol protective colloid asa sizing agent for glass fibers UNILEVER PATENT HOLDINGS B.V. (NL) 1994-11-15 US disclosed
US-5342551-A Containing monoethanolamine citrate, coupler, solvent, alkali CELLO CORPORATION (US) 1994-08-30 US disclosed
EP-0489878-A1 EMULSION POLYMERISATION VINAMUL LTD. (GB) 1992-06-17 EP disclosed
WO-1992000335-A1 EMULSION POLYMERISATION VINAMUL LIMITED (GB) 1992-01-09 WO disclosed
EP-0097291-B1 DYE PREPARATIONS BAYER AG (DE) 1985-12-11 EP disclosed
US-4502863-A Solid dyestuff formulations containing ethylenically unsaturated acid, ester and acrylonitrile copolymer BAYER AKTIENGESELLSCHAFT (DE) 1985-03-05 US disclosed
EP-0097291-A1 Dye preparations BAYER AG (DE) 1984-01-04 EP disclosed
EP-0058865-A2 Process for the manufacture of polymer-pigment preparations, and their use BAYER AG (DE) 1982-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260070309-A1 POLYHYDROXYALKANOATE-BASED PACKAGING FILMS AND ARTICLES MADE THEREWITH PHB2, PWWP2B, PHB1 CA1 4363/4885CA2 2684/4885CA4 2897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.